| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.28 | 0.05 |